• Diagnosis​ Info ​and​ ​General​ ​Questions

  SCD Therapies Too Costly, ICER Says, Calling for Lower Prices

  Posted by Sickle Cell Forum Administrator on March 26, 2020 at 10:02 am

  

  The Institute for Clinical and Economic Review (ICER) says three approved sickle cell disease therapies are too costly based on early effectiveness data. Read more here.

  Do you agree with these findings?

  Sickle Cell Forum Administrator replied 4 years, 1 month ago 0 Member · 0 Replies
• 0 Replies

Log In to Reply